Invention Grant
- Patent Title: Axl fusion proteins as Axl tyrosine kinase inhibitors
- Patent Title (中): Axl融合蛋白作为Axl酪氨酸激酶抑制剂
-
Application No.: US12526094Application Date: 2008-02-07
-
Publication No.: US08168415B2Publication Date: 2012-05-01
- Inventor: Douglas Kim Graham , Susan Louise Sather
- Applicant: Douglas Kim Graham , Susan Louise Sather
- Applicant Address: US CO Denver
- Assignee: The Regents of the University of Colorado
- Current Assignee: The Regents of the University of Colorado
- Current Assignee Address: US CO Denver
- Agency: Sheridan Ross, P.C.
- International Application: PCT/US2008/053337 WO 20080207
- International Announcement: WO2008/098139 WO 20080814
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K38/54
Abstract:
Disclosed are novel inhibitors of the Axl receptor tyrosine kinase (RTK) and methods of using such inhibitors in a variety of therapeutic approaches in the areas of cancer therapy and anti-thrombosis (anti-clotting) therapy.
Public/Granted literature
- US20110014173A1 AXL TYROSINE KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME Public/Granted day:2011-01-20
Information query
